Nasdaq

ThermoGenesis Receives Health Canada Approval of its Next-Generation AXP® II System for Cord Blood Processing

RANCHO CORDOVA, Calif., June 18, 2019 /PRNewswire/ -- ThermoGenesis Corp., a wholly owned subsidiary of Cesca Therapeutics (Nasdaq: KOOL), and a market leader in automated cellular processing, today ...
Nasdaq

Cordlife to Use the ThermoGenesis AXP® II System for Rapid Processing of Cord Blood Units in India

RANCHO CORDOVA, Calif., June 25, 2019 /PRNewswire/ -- ThermoGenesis Corp., a wholly owned subsidiary of Cesca Therapeutics (Nasdaq: KOOL), and a market leader in automated cellular processing, today ...
Business Insider

ThermoGenesis Receives Health Canada Approval of its PXP System for Automated Processing of Bone Marrow Cells

RANCHO CORDOVA, Calif., Feb. 25, 2019 /PRNewswire/ -- ThermoGenesis Corp, a private corporation owned by Cesca Therapeutics (Nasdaq: KOOL), and a market leader in automated cellular processing and ...
FierceBiotech

ThermoGenesis and TotipotentRx Announce Definitive Merger Agreement

RANCHO CORDOVA, Calif. and LOS ANGELES, July 16, 2013 (GLOBE NEWSWIRE) -- ThermoGenesis Corp. (Nasdaq:KOOL) ("ThermoGenesis"), a leading supplier of enabling technologies for the processing and ...
Reuters

ThermoGenesis' cell processing device gets Indian approval

April 13 (Reuters) - ThermoGenesis Corp said its device, used in processing stem cells from bone marrow, got Indian marketing approval, sending its shares up as much as 8 percent. Sign up here. The ...